PerQHern awarded €2.9 million from the Government of Ireland's Disruptive Technologies Innovation Fund.
Fantastic news for PerQHern today. We have been awarded €2.9 million from the Government of Ireland's Disruptive Technologies Innovation Fund.
In collaboration with our partners:
Integer Holdings Corporation, Aran Biomedical and Arrotek Medical Ltd this funding will enable PerQHern to advance our development and enter the second phase of preclinical trials.
Grateful thanks to the Department of Enterprise, Tourism and Employment, Minister Peter Burke TD, Minister James Lawless TD, Enterprise Ireland and Jenny Melia CEO Enterprise Ireland.